Lipocine to Present at 36th Annual Roth Conference

SALT LAKE CITY, March 6, 2024 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company focused on treating Central Nervous System (CNS) disorders, today announced that Dr. Mahesh V. Patel, President and Chief Executive Officer, will participate in a fireside chat and meet with investors at the 36^th Annual Roth Conference, to take place in Laguna Niguel, CA, on March 18.

Read more at prnewswire.com